HOME > COMPANY > Company History
 
2006.06.25 Received a prize from Secretary of the Ministry of Environment
2006.04.27 Synthesized MRI contrast(Gadodiamide) secondly in the world
2006.04.06 Published overseas Convertible Bond (8 million dollar)
2005.03.18 The approval of COS (Certification Of Suitability of Monographs of the European Pharmacopoeia) for Aceclofenac from EDQM
2005.02.25 Received a prize as merit exporter from Secretary of the Ministry of Health and Welfare
2004.12.14 Published overseas Bond with Warrant (3 million dollar)
2004.11.10 Obtained patent of optically active Serin derivatives (Droxidopa Anti parkinsonian)
2004.08.04 Selected as INNO-BIZ company (Innovation Business company) by Small and Medium Business Administration
2004.07.02 Synthesized MRI contrast(Gadopentetic Acid Monomeglumine Salt) secondly in the world
2004.02.06 Listed on the Korea Securities Dealers Automated Quotations(KOSDAQ)
 
2002.03.08 The Approval of COS (Certification Of Suitability of Monographs of the European Pharmacopoeia) for Acamprosate Calcium from EDQM
2001.10.30 The Approval of Good Manufacturing Practice for API (Korea Food & Drug Administration)
2001.01.12 The movement of head office to Ansan-si, Gyeonggi-doThe company name was altered from ESTECH CHEMICAL to ESTECHPHARMA CO., LTD.
2000.01.29 Synthesized " Polysaccharide Iron Complex ", anti-anemia, secondly in the world
2000.01.17 The costruction of new BGMP plant in Ansan, southwest of Seoul
 
1999.05.27 Synthesized " Triflusal ", anti-thrombotic, secondly in the world
1999.01.22 Synthesized " Acamprosate calcium ", treatment of alcoholism, secondly in the world
1997.12.13 Synthesized " Policresulen ", Antiseptics, Disinfectants, secondly in the world
1997.04.15 Synthesized " Aemetacin ", Anti-inflammatory, Anlgesic(NSAIDs), thirdly in the world
1996.06.01 Established ESTECH CHEMICAL
 
Top